Arbital Health Raises $31 Million in Series B Funding to Enhance Value-Based Care Infrastructure

Arbital Health Secures $31M Series B Funding

Arbital Health, a prominent player in healthcare technology, has confirmed a successful $31 million Series B funding round led by Valtruis, with additional backing from existing investors such as Transformation Capital, Shaper Capital, and Healthy Ventures. This significant financial boost aims to expand Arbital's capabilities geared towards managing risk-based contracts in the evolving landscape of value-based care.

The healthcare industry faces increasing pressure to adopt outcomes-focused payment models. Arbital Health's innovative platform is central to easing the complexity and administrative burdens that hospitals and insurance providers face when they transition to performance-based payment systems. The funding will facilitate an increase in Arkital's payer and provider services, thereby enhancing their ability to monitor, manage, and reconcile value-based care contracts.

About the Investment

Valtruis’s Managing Director, Mike Spadafore, expressed that Arbital Health delivers essential infrastructure needed within the healthcare sector. This fresh capital will also be allocated towards augmenting Arbital's market-leading actuarial team and enhancing its AI-powered platform, which is constructed to support better patient outcomes as well as sustainable financial performance.

Arbital Health’s platform features an advanced Adjudication Module and an Overall Risk Performance Dashboard, which provides a consolidated view of monthly financial performance across multiple contracts. This enables healthcare stakeholders to identify trends over time and make informed, scalable decisions about value-based care strategies.

The AI-Powered Advantage

One of Arbital Health's core offerings is its AI capabilities that furnish providers and payers with insights driven by actuarial data. The platform includes performance monitor and insights modules that spotlight critical performance indicators, reveal risk factors, and suggest improvement strategies that enhance patient engagement and health outcomes.

Since it commenced operations in 2024, Arbital Health has significantly broadened its reach, now collaborating with over 40 payers and providers. This dynamic growth includes onboarding more than 600,000 patient lives to its comprehensive platform. The company also boasts the talent of the leading actuaries specializing in value-based care, responding to the escalating demand for efficient management of complex risk contracts.

Brian Overstreet, Arbital's Co-Founder, President, and CEO, stated: "Value-based care is the most effective method to align financial results with improved patient outcomes. Yet, the processes required to align on outcomes are convoluted, leaving organizations struggling with insufficient tools and transparency. Our goal in establishing Arbital Health was to develop essential infrastructure driven by expert actuarial skills and cutting-edge technology. The new funding will accelerate our mission to change how the industry approaches value-based care."

Building for the Future

This funding marks a pivotal moment not just for Arbital Health but for the healthcare industry as a whole. The demand for a structure that allows for clearer insight and easier management of outcomes and performance is increasing. Arbital Health’s transformative platform represents a significant step forward in the healthcare landscape, empowering healthcare providers and payers alike to make data-informed decisions that lead to better healthcare delivery and improved patient care.

As the organization prepares for a future rife with potential, Arbital Health aims to redefine value-based care in a manner that is sustainable, efficient, and beneficial for all stakeholders involved. The implications of this funding will undoubtedly spur further advancements in the management of risk-based contracts, providing a framework where quality healthcare can thrive.